Drug Trial Radar · NCT03237845
Safety and Efficacy in Adult Subjects With Acute Migraines
Last checked: Nov 19, 2026Latest source record: Feb 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,499
Actual
Start
Jul 27, 2017
Primary completion
Jan 25, 2018
Study completion Jan 31, 2018
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 3, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines
Conditions
- Migraine, With or Without Aura
Interventions
RimegepantDrug
75 mg tablet QD
PlaceboDrug
Placebo tablet to match rimegepant dose QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 Hours post-dose
- Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 Hours
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Coastal Clinical Research
Mobile, Alabama
Thunderbird Internal Medicine / Radiant Research, Inc.
Glendale, Arizona
Woodland Research Northwest, LLC
Rogers, Arkansas
eStudySite
La Mesa, California
Collaborative Neuroscience Network, LLC
Long Beach, California
Pharmacology Research Institute
Los Alamitos, California
Pharmacology Research Institute
Newport Beach, California
Pacific Research Partners LLC
Oakland, California
National Research Institute
Panorama City, California
California Neuroscience Research Medical Group, Inc.
Sherman Oaks, California
Clinical Trials of the Rockies
Denver, Colorado
AGA Clinical Trials
Hialeah, Florida
Clinical Neuroscience Solutions
Jacksonville, Florida
Renstar Medical Research
Ocala, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Meridien Research
Tampa, Florida
Radiant Research, Inc.
Atlanta, Georgia
Savannah Neurology Specialists
Savannah, Georgia
Christie Clinic, LLC
Champaign, Illinois
PMG Research of McFrland Clinic
Ames, Iowa
Heartland Research Associates, LLC
Augusta, Kansas
Heartland Research Associates, LLC
Newton, Kansas
Heartland Research Associates, LLC
Park City, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
MedPharmics, LLC
Metairie, Louisiana
NECCR Primacare Research, LLC
Fall River, Massachusetts
Albuquerque Neuroscience, Inc.
Albuquerque, New Mexico
Radiant Research, Inc.
Jamaica, New York
PMG Research of Raleigh, Inc.
Raleigh, North Carolina
Wake Research Associates, LLC
Raleigh, North Carolina
PMG Research of Wilmington, LLC
Wilmington, North Carolina
Radiant Research, Inc.
Cincinnati, Ohio
Radiant Research, Inc.
Columbus, Ohio
Midwest Clinical Research Center
Dayton, Ohio
Neurology Diagnostics, Inc.
Dayton, Ohio
Aventiv Research, Inc.
Dublin, Ohio
Summit Research Network (Oregon), Inc.
Portland, Oregon
Oregon Center for Clinical Investigations, Inc
Salem, Oregon
Fieve Clinical Research, Inc.
Scranton, Pennsylvania
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.